Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally 2-6-sialylated neolacto-series gangliosides
Open Access
- 1 August 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 12 (8) , 485-497
- https://doi.org/10.1093/glycob/cwf062
Abstract
Production of biochemically defined recombinant mistletoe lectin was achieved by cloning and separate expression of the single catalytically active A-chain and the B-chain with carbohydrate binding properties in Escherichia coli, yielding an active heterodimeric protein named rViscumin (Eck et al. [1999] Eur. J. Biochem., 265, 788–797). Employing solid phase binding assays, rViscumin was shown to preferentially bind to terminally α2-6-sialylated neolacto-series gangliosides IV6Neu5Ac-nLc4Cer, VI6Neu5Ac-nLc6Cer, and VIII6Neu5Ac-nLc8Cer isolated from human granulocytes. Only marginal binding of rViscumin to galactose-terminated neutral GSLs was determined, whereas reinvestigation of ricin specificity demonstrated this lectin as a galactose-binding protein. Human promyelotic HL-60 cells exhibited an IC50 value (half maximum cytotoxicity) of 1.16 pM and human bladder carcinoma 5637 cells of 12.1 pM rViscumin; CHO-K1 cells were resistant to rViscumin treatment up to a concentration of 5.26 nM tested. Quantification of the predominant receptor ganglioside IV6Neu5Ac-nLc4Cer by means of a specific anti-Neu5Acα2-6Galβ1-4GlcNAc-R antibody revealed 3.68 × 106 and 1.54 × 106 receptor molecules per HL-60 and 5637 cell, respectively; CHO-K1 cells were negative, lacking α2-6-sialylated gangliosides. The data imply a direct correlation of rViscumin cytotoxicity and the expression of receptor ganglioside. Moreover, CHO-K1 cells were rendered susceptible toward rViscumin cytotoxicity after exogenous application of human granulocyte gangliosides. Thus, (1) rViscumin has to be considered as a sialic acid–specific rather than a galactose-specific type II ribosome-inactivating protein, and (2) neolacto-series gangliosides with Neu5Acα2-6Galβ1-4GlcNAc-terminus are true functional and physiologically relevant rViscumin receptors.Keywords
This publication has 59 references indexed in Scilit:
- Site-Specific Mutagenesis of Mistletoe Lectin: The Role of RIP Activity in ApoptosisBiochemical and Biophysical Research Communications, 1999
- Primary Structure and Molecular Modeling of Mistletoe Lectin I fromViscum albumBiochemical and Biophysical Research Communications, 1998
- Complete Amino Acid Sequence of the B Chain of Mistletoe Lectin IBiochemical and Biophysical Research Communications, 1998
- Interaction of Mistletoe Toxic Lectin-I with SialoglycoproteinsBiochemical and Biophysical Research Communications, 1995
- The Super-Spinner: A low cost animal cell culture bioreactor for the CO2 incubatorCytotechnology, 1994
- Ribosome-inactivating proteins from plantsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- A New Sulfonated Tetrazolium Salt That Produces a Highly Water-Soluble Formazan Dye.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993
- Ribosomal RNA identity elements for ricin A-chain recognition and catalysisJournal of Molecular Biology, 1992
- A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugatesGlycoconjugate Journal, 1988
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957